PERCEPTIVE ADVISORS LLC

CIK 1224962 · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.14B

Companies

28

Total Filings

74

Lifetime Open-Market Net

$647.93M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SLDB Director 73,107 $7.14 $522.0K $80.60M 7 2026-06-11
MGTX Director 11,281,103 $9.59 $108.19M $178.27M 8 2025-06-16
ADGM Director 9,876,586 $0.74 $7.36M $0 1 2025-02-14
NAUT Director $2.24 $0 3 2024-06-17
VRCA 10%+ Owner 6,722,914 $5.73 $38.52M $54.77M 2 2023-12-26
SLNO 10%+ Owner 2,270,473 $53.01 $120.36M $45.34M 1 2023-09-28
LianBio (LIAN) Delisted Director $0.32 $0 2 2023-06-23
LYRA Director 1,288,446 $0.70 $902.0K $36.00M 2 2023-06-02
CHEMBIO DIAGNOSTICS, INC. (CEMI) Delisted 10%+ Owner 4,863,334 $0.46 $2.21M $451.2K 2 2023-04-20
ALDX 10%+ Owner 10,801,985 $1.76 $19.01M $11.27M 2 2022-08-04
Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted Director 4,843,095 $18.07 $87.51M $15.00M 1 2021-07-09
VBI Vaccines Inc/BC (VBIV) Delisted 10%+ Owner 0 $0.07 $0 $35.56M 3 2021-06-30
Landos Biopharma, Inc. (LABP) Delisted Director 2,941,769 $22.93 $67.45M $100.00M 1 2021-02-08
Astria Therapeutics, Inc. (CATB) Delisted Director $8.54 $0 1 2021-02-03
MOTS 10%+ Owner 3,210,542 $0.00 $321 $10.79M 3 2021-01-22
CRNX 10%+ Owner 3,659,381 $34.47 $126.14M $45.00M 1 2020-04-20
ALBIREO PHARMA, INC. (ALBO) Delisted 10%+ Owner 1,960,139 $44.15 $86.54M $16.12M 1 2020-02-04
AMICUS THERAPEUTICS, INC. (FOLD) Delisted 10%+ Owner 20,724,424 $14.49 $300.30M $0 1 2019-02-19
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted 10%+ Owner 4,313,611 $6.22 $26.83M $79.13M 2 2018-03-26
Corium International, Inc. (CORI) Delisted 10%+ Owner 5,847,133 $6.96M 1 2017-07-05
TALPHERA, INC. (ACRX) Delisted 10%+ Owner 6,467,560 $0.86 $5.56M $11.38M 2 2013-11-12
Aegerion Pharmaceuticals, Inc. (AEGR) Delisted 10%+ Owner 2,823,426 -$153.82M 4 2013-09-09
REPROS THERAPEUTICS INC. (RPRX.Z) Delisted 10%+ Owner $0 4 2013-02-13
SYNAGEVA BIOPHARMA CORP (GEVA) Delisted 10%+ Owner 0 $0 1 2011-11-09
REPROS THERAPEUTICS INC. (RPRXZ) Delisted 10%+ Owner 1,982,460 $12.38M 3 2011-08-24
PENWEST PHARMACEUTICALS CO (PPCO) Delisted 10%+ Owner 6,476,446 $279.5K 7 2009-03-31
IDEV 10%+ Owner 7,891,067 $90.39 $713.27M $5.16M 2 2009-03-09
XTLB 10%+ Owner 3,069,180 $2.13 $6.54M $57.30M 5 2008-06-11

Recent Filings · Page 2 of 8

74 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-06-08 SLDB Grant (A) $0 EDGAR
2023-06-02 LYRA Buy (P) +14,443,328 $36.00M EDGAR
2023-05-15 MGTX Buy (P) +13,043,478 $75.00M EDGAR
2023-04-20 CHEMBIO DIAGNOSTICS, INC. (CEMI) Delisted Buy (P) +626,400 $281.0K EDGAR
2023-04-13 CHEMBIO DIAGNOSTICS, INC. (CEMI) Delisted Buy (P) +387,000 $170.3K EDGAR
2022-08-04 ALDX Buy (P) +1,237,218 $6.92M EDGAR
2022-06-27 LianBio (LIAN) Delisted Grant (A) $0 EDGAR
2022-06-17 NAUT Grant (A) $0 EDGAR
2022-06-13 MGTX Grant (A) $0 EDGAR
2022-06-09 SLDB Grant (A) $0 EDGAR
Showing 1120 of 74
Page 2 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.